(First posted 5/5/22)
Late breaking abstracts
Rolling basis during meeting
The European Hematology Association 2022 Congress (EHA 2022) takes place from June 9-12, 2022 as a hybrid congress; both online and in-person in Vienna, Austria. On-demand content is made available on the congress platform starting June 20 and the EHA2022 virtual thematic days take place from June 15-17, 2022.
Abstracts were accepted from January 1 - March 1, 2022. Abstracts will be made available May 12, 2022 4pm CEST and late breaking abstracts will be released starting June 2, 2022 4pm CEST. EHA 2022 (which focuses on blood cancers) will be the first hybrid EHA congress as it returns to a partially in-person meeting.
Want to get Catalyst Events and stocks to watch sent directly to your inbox each week? sign up for our free weekly newsletter
While abstracts will be released on May 12, “the embargo for presidential symposium presentations is lifted at the start of the Presidential Symposium; Saturday, June 11, 14:45 CEST, unless the abstract is part of an official EHA Press Briefing in which case the embargo lifts on the date and time of the Press Briefing (if earlier).” The embargo is lifted on June 10 for oral presentation abstracts and Poster presentations, and the embargo is lifted on June 12 for late-breaking oral presentations. Up until these dates, only the data in the abstracts is allowed to be announced.
The American Society of Clinical Oncology Annual Meeting (ASCO 2022) is another large oncology congress taking place next month (from June 3-7, 2022) and we will be following it closely. (we talked briefly about ASCO HERE). Watch for more info on ASCO soon including BPIQ picks and further in depth info on several company presentations.
We will be monitoring companies involved in EHA and ASCO closely and update this post as companies announce their involvement. Currently as of 5/5/22, CRBU is the only company in the BPIQ database which has announced its involvement in EHA.
If you are serious about investing in biotech stocks BPIQ is the research companion that will take you to the next level.
Save yourself time by accessing our database of over 550 companies, 1,800+ of their drug assets, and tools including: Catalyst Calendar, Big Movers, Company Pipelines, and more!
P.S. We are currently running a sale - lock in the price before it's gone
See what our members are saying about us:
Mike from United States
“Really loving the site over the competitor... like the layout and speed over the competition...like the individual pages for each drug/treatment”
Carl from United States
“I like your service. I haven’t seen anyone else doing something similar...nothing like this available for retail.”
Essey from Canada
“Love what you’re doing, this website is awesome.”
James from United States
Great site and I see it’s a family run business, great job.”